Gene · 2671
GFER: growth factor, augmenter of liver regeneration
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GFER: growth factor, augmenter of liver regeneration. Genes, record 2671. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2671
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P55789 | FAD-linked sulfhydryl oxidase ALR | 205 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents23
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 48343 | P55789 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1241 | P55789 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4437 | P55789 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1241 | P55789 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4437 | P55789 | Espacenet |
| JP 2023012509 A | 2023-01-25 | 1720 | P55789 | Espacenet |
| US 11464836 B2 | 2022-10-11 | 1720 | P55789 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 36492 | P55789 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 139463 | P55789 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 4417 | P55789 | Espacenet |
1 to 10 of 23
See all 23 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,005
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GFER papers | Newest fiscal year |
|---|---|---|---|
| R01GM061721 | BIOGENESIS OF THE MITOCHONDRIAL INNER MEMBRANE | 10 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| ZIAHD008814 | Mammalian iron-sulfur cluster biogenesis | 4 | 2025 |
| ZIAHD001602 | Regulation Of Intracellular Iron Metabolism | 3 | 2025 |
| K08AR077100 | The Retroelement LINE1 and the DNA Sensor IF16 in Sjogren's Syndrome | 2 | 2025 |
| K12EY022299 | Michigan Vision Clinician Scientist Development Program | 2 | 2025 |
| P01AI063302 | The intersection of innate and adaptive immunity to intracellular pathogens | 2 | 2025 |
| P20GM109025 | Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission | 2 | 2025 |
| P30CA006516 | Dana-Farber/Harvard Cancer Center | 2 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,005Source NIH's project files
See all 1,005 nih grantsPapers1,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum Olink Proteomics Reveals Novel Biomarkers for Early Diagnosis of Hepatocellular Carcinoma. | J Proteome Res | 2026 | 42695890 | PubTator, text mining | PubMed |
| ALR couples IMS redox and heme biosynthesis beyond the disulfide relay. | Sci Adv | 2026 | 42467788 | PubTator, text mining | PubMed |
| APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis. | Int J Mol Sci | 2026 | 42450078 | PubTator, text mining | PubMed |
| Prognostic Model Based on Sex, ALBI Grade, and ALR in Intermediate-to-Advanced HCC Patients Receiving Targeted Therapy Combined with ICIs and Interventional Treatment. | Cancers (Basel) | 2026 | 42449608 | PubTator, text mining | PubMed |
| Piezo1 Activation by Shear Stress Induces Corneal Epithelial Homeostasis Disruption. | Invest Ophthalmol Vis Sci | 2026 | 42439605 | PubTator, text mining | PubMed |
| Therapeutic Stress-Induced Remodeling of Transposable Elements and TE-Gene Chimeras in KYSE150 Esophageal Squamous Cell Carcinoma Cells. | Int J Mol Sci | 2026 | 42074115 | PubTator, text mining | PubMed |
| Long-Read HiFi Genome Sequencing Resolves Retrotransposon-Mediated Deletions in TANGO2 Deficiency Disorder. | Neurol Genet | 2026 | 42063611 | PubTator, text mining | PubMed |
| Comparative Genomics Reveals the Ancestral Recombination Landscape of Placental Mammals. | bioRxiv | 2026 | 41959276 | PubTator, text mining | PubMed |
| Publisher Correction: Long-read technologies identify a hidden LINE-1/ERV1 insertion in IQCB1 as causative variant for Senior-Løken syndrome. | NPJ Genom Med | 2026 | 41876567 | PubTator, text mining | PubMed |
| Unified phase separation drives DNA-induced inflammasome activation of the AIM2-like receptors. | Cell Rep | 2026 | 41811848 | PubTator, text mining | PubMed |
1 to 10 of 1,506
See all 1,506 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2671
GET https://conductscience.org/api/genes/v1/2671/patents?page=2